1.Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin—United States, 1989-93. MMWR 1993;42:597–609.
2.Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(RR-12):1–13.
3.Weinstein, MR, Dedier, H, Brunton, J, Campbell, I, Conly, JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999;29:361–366.
4.O'Donovan, CA, Fan-Havard, P, Tecson-Tumang, FT, Smith, SM, Eng, RH. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105–109.
5.Montecalvo, MA, Horowitz, H, Wormser, GP, Seiter, K, Carbonaro, CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1995;39:794.
6.Chia, JKS, Nakata, MM, Park, S, Lewis, RP, Mckee, B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995;21:1520.
7.Wong, MT, Kauffman, CA, Standiford, HC, et al. Clinical efficacy and safety of a novel glycopeptide, ramoplanin, in the contamination of the gastrointestinal system of patients colonized with vancomycin-resistant Enterococcus. Clin Infect Dis 1999;29:968.
8.Facklam, RR, Collins, MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731–734.
9.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993. NCCLS document M7-A3.